A pilot study of thymosin-alpha 1 therapy for chronic hepatitis D.
Zavaglia
C
C
Divisione di Medicina Generale, Ospedale Niguarda, Milano, Italy.
Bottelli
R
R
Smedile
A
A
Iamoni
G
G
Mondazzi
L
L
Airoldi
A
A
Lanzani
F
F
Idéo
G
G
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D003699:Hepatitis D / Q000097:blood / Q000188:drug therapy*; D006521:Hepatitis, Chronic / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012367:RNA, Viral / Q000097:blood; D000077596:Thymalfasin; D013947:Thymosin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D012367:RNA, Viral; D013947:Thymosin; D000410:Alanine Transaminase; D000077596:Thymalfasin